Table 3.
Correlation between KRAS, BRAF mutations and clinicopathological parameters in colorectal cancer (%)
| Terms | All | Wild type | KRAS Mutation | BRAF Mutation |
|---|---|---|---|---|
| No.of patients | 159 | 122 | 28 (17,6%) | 10 (6,3%) |
| Median age | 61,7 | |||
| Gender | ||||
| Male | 90 | 69 | 18 (20%) | 3 (3,3%) |
| Female | 69 | 53 | 10 (14,5%) | 7 (10,1%) |
| Differentiation | ||||
| Poor | 12 | 11 | / | 1 (8,3%) |
| Moderate | 76 | 57 | 17 (22%) | 3 (3,9%) |
| Mucinose | 16 | 12 | 3 (18,7%) | 1 (6,2%) |
| Well | 52 | 39 | 8 (15,3%) | 5 (9,6%) |
| UICC classification | ||||
| I | 24 | 17 | 5 (20,8) | 2 (8,3%) |
| IIA | 36 | 26 | 7 (19,4) | 3 (8,3%) |
| IIIA | 10 | 9 | 1 (10%) | / |
| IIIB | 70 | 55 | 11 (16%) | 5 (7.1%) |
| IIIC | 4 | 3 | 1 (25%) | / |
| IV | 15 | 12 | 3 (20%) | / |